Relationship between Procalcitonin Levels (PCT) and Disease Severity in Hospitalized Patients Confirmed Positive for COVID-19

Authors

  • Rizana Fajrunni'mah Department of Medical Laboratory Technology, Poltekkes Kemenkes Jakarta III, Bekasi, West Java, Indonesia
  • Fransiska Rada Department of Medical Laboratory Technology, Poltekkes Kemenkes Jakarta III, Bekasi, West Java, Indonesia
  • Retno Martini Widhyasih Department of Medical Laboratory Technology, Poltekkes Kemenkes Jakarta III, Bekasi, West Java, Indonesia

DOI:

https://doi.org/10.31965/infokes.Vol20.Iss1.638

Keywords:

COVID-19, Procalcitonin (PCT), Disease Severity

Abstract

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This disease attacks the respiratory tract and spreads rapidly almost throughout the world, hence, WHO has declared COVID-19 as a global pandemic. The presence of inflammation and bacterial co-infection in COVID-19 hospitalized patients can increase procalcitonin (PCT) levels as a biomarker of inflammation. Elevated PCT levels are also associated with disease severity. The objective of this study is to determine the relationship between PCT levels and disease severity in hospitalized patients who are confirmed positive for COVID-19. This research method is analytic observational with cross sectional design. The sample is in the form of medical record data for 180 COVID-19 patients who are hospitalized at Bhayangkara Tk. I Raden Said Sukanto Hospital, Jakarta for the period July-December 2020. The relationship between PCT levels and disease severity was statistically analyzed using the Chi Square test. The results of this study were 109 (60.6%) men and 71 (39.4%) women with the highest age group being 46-59 years. The average PCT level was 10.38 ng/mL with the lowest level of 0.01 ng/mL and the highest level of 282.00 ng/mL. PCT levels <0.5 ng/mL were discovered in 111 patients (61.7%) and PCT levels 0.5 ng/mL in 69 patients (38.3%). The severity of disease in mild-moderate illness was 87 patients (48.4%), severe was 35 patients (19.4%), and critical was 58 patients (32.2%). The Chi Square test showed that there was a relationship between PCT levels and disease severity in COVID-19 patients (p = 0.000). The higher the PCT level, the higher the severity of the disease, thus, PCT can be used as an indicator to see the severity of the disease.

Downloads

Download data is not yet available.

References

Ahmed, S., Jafri, L., Hoodbhoy, Z., & Siddiqui, I. (2021). Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian Journal of Critical Care Medicine, 25(1), 77. https://doi.org/10.5005/jp-journals-10071-23706 DOI: https://doi.org/10.5005/jp-journals-10071-23706

Cai, H. (2020). Sex difference and smoking predisposition in patients with COVID-19. The Lancet Respiratory Medicine, 8(4), e20. https://doi.org/10.1016/S2213-2600(20)30117-X DOI: https://doi.org/10.1016/S2213-2600(20)30117-X

Cecconi, M., Piovani, D., Brunetta, E., Aghemo, A., Greco, M., Ciccarelli, M., Vespa, E. (2020). Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy. Journal of Clinical Medicine, 9(5), 1548. https://doi.org/10.3390/jcm9051548 DOI: https://doi.org/10.3390/jcm9051548

Chen, G., Wu, D. I., Guo, W., Cao, Y., Huang, D., Wang, H., ... & Ning, Q. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. Journal of Clinical Investigation, 130(5), 2620–2629. https://doi.org/10.1172/JCI137244 DOI: https://doi.org/10.1172/JCI137244

Chen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., ... & Zhong, N. (2020). Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. Journal of Allergy and Clinical Immunology, 146(1), 89-100. https://doi.org/10.1016/j.jaci.2020.05.003 DOI: https://doi.org/10.1016/j.jaci.2020.05.003

Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ning, Q. (2020). Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study. BMJ, 368, 1–12. https://doi.org/https://doi.org/10.1136/bmj.m1091 DOI: https://doi.org/10.1136/bmj.m1091

Cleland, D. A., & Eranki, A. P. (2020). Procalcitonin. Florida: StatPearls Publishing.

Das, B. (2020). A race against time: Chasing procalcitonin biomarker in early sepsis diagnosis and prognosis of COVID-19 patients. Express Healthcare. Retrieved from https://www.expresshealthcare.in/covid19-updates/a-race-against-time-chasing-procalcitonin-biomarker-in-early-sepsis-diagnosis-and-prognosis-of-covid-19-patients/424660/

Dolci, A., Robbiano, C., Aloisio, E., Chibireva, M., Serafini, L., Falvella, F. S., ... & Panteghini, M.. (2020). Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients. Clinical Chemistry and Laboratory Medicine (CCLM), 59(2), 433–440. https://doi.org/10.1515/cclm-2020-1361 DOI: https://doi.org/10.1515/cclm-2020-1361

Elshazli, R. M., Toraih, E. A., Elgaml, A., El-Mowafy, M., El-Mesery, M., Amin, M. N., ... & Kandil, E. (2020). Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PloS One, 15(8), 1–20. https://doi.org/10.1371/journal.pone.0238160 DOI: https://doi.org/10.1371/journal.pone.0238160

Fang, L., Karakiulakis, G. and Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine, 8(4), e21. https://doi.org/10.1016/S2213-2600(20)30116-8 DOI: https://doi.org/10.1016/S2213-2600(20)30116-8

Gregoriano, C., Koch, D., Haubitz, S., Conen, A., Fux, C. A., Mueller, B., ... & Schuetz, P. (2020). Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis. Swiss Medical Weekly, 150, w20316. https://doi.org/10.4414/smw.2020.20316 DOI: https://doi.org/10.4414/smw.2020.20316

Hu, R., Han, C., Pei, S., Yin, M., & Chen, X. (2020). Procalcitonin levels in COVID-19 patients. International Journal of Antimicrobial Agents, 56(2), 106051. https://doi.org/10.1016/j.ijantimicag.2020.106051 DOI: https://doi.org/10.1016/j.ijantimicag.2020.106051

Huang, I., Pranata, R., Lim, M. A., Oehadian, A., & Alisjahbana, B. (2020). C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Therapeutic Advances in Respiratory Disease, 14, 1–14. https://doi.org/10.1177/1753466620937175 DOI: https://doi.org/10.1177/1753466620937175

Ji, P., Zhu, J., Zhong, Z., Li, H., Pang, J., Li, B., & Zhang, J. (2020). Association of elevated inflammatory markers and severe COVID-19: A meta-analysis. Medicine, 99(47), e23315. https://doi.org/10.1097/MD.0000000000023315. DOI: https://doi.org/10.1097/MD.0000000000023315

Kementerian Kesehatan Republik Indonesia. (2020). Pedoman Pencegahan dan Penanggulangan COVID-19 (Revisi 5). Jakarta: Kementerian Kesehatan Republik Indonesia.

Levani, Y., Prastya, A. D., & Mawaddatunnadila, S. (2021). Coronavirus disease 2019 (COVID-19): patogenesis, manifestasi klinis dan pilihan terapi. Jurnal Kedokteran dan kesehatan, 17(1), 44-57. DOI: https://doi.org/10.26714/magnamed.6.1.2019.31-37

Li, C., Zhao, C., Bao, J., Tang, B., Wang, Y., & Gu, B. (2020). Laboratory diagnosis of coronavirus disease-2019 (COVID-19). Clinica Chimica Acta, 510, 35-46. https://doi.org/10.1016/j.cca.2020.06.045 DOI: https://doi.org/10.1016/j.cca.2020.06.045

Li, Q., Ling, Y., Zhang, J., Li, W., Zhang, X., Jin, Y., Lu, H. (2020). Clinical characteristics of SARS-CoV-2 infections involving 325 hospitalized patients outside Wuhan. Research Square, 1–15. https://doi.org/10.21203/rs.3.rs-18699/v1 DOI: https://doi.org/10.21203/rs.3.rs-18699/v1

Lippi, G., & Plebani, M. (2020). Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clinica Chimica Acta, 505, 190-191. https://doi.org/10.1016/j.cca.2020.03.004 DOI: https://doi.org/10.1016/j.cca.2020.03.004

Liu, Z. M., Li, J. P., Wang, S. P., Chen, D. Y., Zeng, W., Chen, S. C., ... & Wu, X. H. (2020). Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19. International Journal of Medical Sciences, 17(16), 2468-2476. https://doi.org/10.7150/ijms.48396 DOI: https://doi.org/10.7150/ijms.48396

Luo, X., Xia, H., Yang, W., Wang, B., Guo, T., Xiong, J., Zhou, W. (2020). Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China. MedRxiv. https://doi.org/10.1101/2020.03.19.20033175 DOI: https://doi.org/10.1101/2020.03.19.20033175

Meisner, M. (2014). Update on procalcitonin measurements. Annals of Laboratory Medicine, 34(4), 263-273. https://doi.org/10.3343/alm.2014.34.4.263 DOI: https://doi.org/10.3343/alm.2014.34.4.263

Minuljo, T. T., Prima, Y., Anindita, C., Nugroho, H., Seno, H., Gde, T., … Sofro, U. (2020). Karakteristik dan Keluaran Pasien COVID-19 dengan DM di RS Umum Pusat Dr . Kariadi. Medica Hospitalia, 7(1A), 150–158. https://doi.org/10.36408/mhjcm.v7i1A.473 DOI: https://doi.org/10.36408/mhjcm.v7i1A.473

Peckham, H., de Gruijter, N. M., Raine, C., Radziszewska, A., Ciurtin, C., Wedderburn, L. R., … Deakin, C. T. (2020). Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications, 11(1), 6317. https://doi.org/10.1038/s41467-020-19741-6 DOI: https://doi.org/10.1038/s41467-020-19741-6

Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020). Biomarkers associated with COVID-19 disease progression. Critical Reviews in Clinical Laboratory Sciences, 57(6), 389–399. https://doi.org/10.1080/10408363.2020.1770685 DOI: https://doi.org/10.1080/10408363.2020.1770685

Satuan Gugus Tugas COVID-19. (2021). Data COVID-19 Indonesia. Jakarta: Satuan Gugus Tugas COVID-19.

Schuetz, P. (2020). The role of procalcitonin for risk assessment and treatment of COVID-19 Patients. Health Management, 20(5), 380-382.

Shah, V. (2020). Meaning of Elevated Procalcitonin Unclear in COVID-19. Boston: Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital.

Soeroto, A. Y., Santoso, P., Pranggono, E. H., Kulsum, I. D., Suryadinata, H,… & Raditya, F. (2020). Kompendium Diagnostik dan Pengobatan COVID-19 (INTERIM), Perhimpunan Respiralogi Indonesia (PERPARI). Indonesian Journal of CHEST: Critical and Emergency Medicine, 7(1), 17-59.

Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., Yulianti, M., Herikurniawan, H., ... & Yunihastuti, E. (2020). Coronavirus disease 2019: Tinjauan literatur terkini. Jurnal penyakit dalam Indonesia, 7(1), 45-67. http://dx.doi.org/10.7454/jpdi.v7i1.415 DOI: https://doi.org/10.7454/jpdi.v7i1.415

Tomo, S., Karli, S., Dharmalingam, K., Yadav, D., & Sharma, P. (2020). The clinical laboratory: a key player in diagnosis and management of COVID-19. EJIFCC, 31(4), 326-346.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., … Xiong, Y. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585 DOI: https://doi.org/10.1001/jama.2020.1585

WHO. (2020a). Corona Virus Disease (COVID-19). Geneva: World Health Organization.

WHO.(2020b).Tes Diagnostik untuk SARS-CoV-2. Geneva: World Health Organization.

WHO. (2021). Corona Virus Disease (COVID-19). World Health Organization.

Xu, J. B., Xu, C., Zhang, R. B., Wu, M., Pan, C. K., Li, X. J., ... & Zhu, S. (2020). Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China. Scientific reports, 10(1), 1-10. https://doi.org/10.1038/s41598-020-72164-7 DOI: https://doi.org/10.1038/s41598-020-72164-7

Downloads

Published

2022-06-27

How to Cite

Fajrunni'mah, R., Rada, F. ., & Widhyasih, R. M. . (2022). Relationship between Procalcitonin Levels (PCT) and Disease Severity in Hospitalized Patients Confirmed Positive for COVID-19. JURNAL INFO KESEHATAN, 20(1), 41–48. https://doi.org/10.31965/infokes.Vol20.Iss1.638

Issue

Section

Original Articles

Similar Articles

1 2 3 4 5 6 > >> 

You may also start an advanced similarity search for this article.